Cited by 58Estrogen and related hormone effectsEffects and risks of endocrine disrupting chemicalsReceptor Mechanisms and Signaling

Agonistic and Antagonistic Effects of Clomiphene Citrate and Its Isomers1

Clark, James H., Guthrie, Sylvia C.·1981·Biology of Reproduction

Abstract

The agonistic and antagonistic properties of clomiphene citrate (CL) and its isomers were examined in the rat uterus. Immature rats (21 days old) were injected with various doses of estradiol benzoate (EB), CL, zuclomiphene (ZUC, cis isomer), and enclomiphene (ENC, trans isomer), and uterine weight or epithelial cell height was measured. EB treatment produced a typical dose-response curve for uterine weight with a steep slope, while the curves resulting from treatment with CL, ZUC, or ENC were attenuated with a very shallow slope. These differences in shapes of the dose-response curves render the determination of relative potency estimates inaccurate and misleading. In contrast, the shapes of the dose-response curves for epithelial cell hypertrophy were similar for all four compounds. EB was more potent than any form of clomiphene; however, the maximum extent of cellular hypertrophy was not as great. The half maximal dose for each compound was EB, 0.35 ± 0.04 µg; ENC, 25.0 ± 2.0 µg; CL, 35.0 ± 3.1 µg; and ZUC, 65.0 ± 7.1 µg. The ability of these drugs to antagonize the action of EB was examined by injecting EB plus CL, ZUC, or ENC and measuring the uterine weight or epithelial cell hypertrophy 72 h later. All three forms of the drug were antagonistic to EB-induced uterine weight gain over the same dose ranges in which they were agonistic by themselves. No antagonistic effects were observed on estradiol stimulation of epithelial cell hypertrophy. These data show that CL and its isomers are fully capable of stimulating epithelial cell hypertrophy in the rat uterus, and thus, valid relative potency estimates can be obtained with this response. This is not true when uterine weight gain is used because differential cell stimulation is not taken into account. In addition, CL and its isomers are agonistic and antagonistic over the same dose ranges when uterine weight gain is used; however, no antagonism of estrogen-stimulated cellular hypertrophy is measured. Therefore, broad generalizations concerning the estrogenicity or anti-estrogenicity of these compounds are not warranted and can be made only when specific end-points are evaluated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1095/biolreprod25.3.667

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Enclomiphene is the trans-isomer of clomiphene and a relatively pure oestradiol antagonist.

    “Enclomiphene, the trans-isomer of clomiphene is a relatively pure oestradiol antagonist, 113”

    From Hypogonadism and male obesity: Focus on unresolved questions (2018) · cites this paper as [113]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Bliss, C. I. (1952). The Statistics of Bioassay. Aca- demic Press, New York. pp. 488-494.

Cited by

Sorted by citations

Authors
Clark, J. H., & Guthrie, S. C.
Affiliations
Baylor College of Medicine (US)
Venue
Biology of Reproduction
Published
1981-10-01
Volume
25
Issue
3
Pages
667-672
ISSN
  • 0006-3363 (ISSN-L)
  • 1529-7268
OpenAlex
W2012256669
Cited by
58
References
22
Citations by year
2022: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Locations
  • Biology of Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
clomiphene citrate, estradiol benzoate, uterine weight, dose-response curves, relative potency, estrogen antagonism, estrogenic activity, immature rats
MeSH terms
Animals, Clomiphene, Dose-Response Relationship, Drug, Epithelium, Estradiol, Female, Isomerism, Rats, Inbred Strains, Uterus, Estradiol Congeners, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review